OLD National Bancorp IN Sells 20,240 Shares of Albemarle Corporation $ALB

Posted by Francis Steltz on Jun 26th, 2026

OLD National Bancorp IN trimmed its holdings in Albemarle Corporation (NYSE:ALB – Free Report) by 14.7% in the first quarter, Holdings Channel reports. The institutional investor owned 117,025 shares of the specialty chemicals company’s stock after selling 20,240 shares during the quarter. OLD National Bancorp IN’s holdings in Albemarle were worth $21,009,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Strategic Advocates LLC bought a new position in shares of Albemarle in the third quarter worth $25,000. MH & Associates Securities Management Corp ADV bought a new stake in shares of Albemarle during the 4th quarter valued at $26,000. BOKF NA lifted its holdings in Albemarle by 5,771.4% during the 3rd quarter. BOKF NA now owns 411 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 404 shares in the last quarter. Elyxium Wealth LLC purchased a new stake in Albemarle during the 4th quarter worth about $34,000. Finally, EverSource Wealth Advisors LLC boosted its stake in Albemarle by 536.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock worth $36,000 after purchasing an additional 483 shares during the period. Institutional investors own 92.87% of the company’s stock.

Insider Buying and Selling

In other news, CEO J Kent Masters sold 16,393 shares of the stock in a transaction on Friday, May 15th. The shares were sold at an average price of $183.72, for a total value of $3,011,721.96. Following the transaction, the chief executive officer owned 87,519 shares of the company’s stock, valued at $16,078,990.68. This represents a 15.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.42% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on ALB. Deutsche Bank Aktiengesellschaft upped their price target on Albemarle from $210.00 to $250.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Royal Bank Of Canada boosted their price objective on shares of Albemarle from $253.00 to $257.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Citigroup raised shares of Albemarle from a “neutral” rating to a “buy” rating and set a $225.00 target price on the stock in a report on Thursday, June 18th. HSBC increased their target price on shares of Albemarle from $200.00 to $220.00 and gave the stock a “buy” rating in a research note on Monday, April 27th. Finally, Vertical Research raised shares of Albemarle from a “hold” rating to a “buy” rating and set a $224.00 price target for the company in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $202.54.

Read Our Latest Analysis on ALB

Albemarle Stock Performance

Shares of ALB opened at $140.76 on Friday. The company has a market cap of $16.60 billion, a PE ratio of -41.28, a price-to-earnings-growth ratio of 0.71 and a beta of 1.30. The company has a current ratio of 2.07, a quick ratio of 1.21 and a debt-to-equity ratio of 0.23. The stock has a 50-day moving average price of $177.67 and a 200-day moving average price of $169.35. Albemarle Corporation has a 12-month low of $60.64 and a 12-month high of $221.00.

Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The specialty chemicals company reported $2.95 EPS for the quarter, topping the consensus estimate of $1.24 by $1.71. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a positive return on equity of 5.22% and a negative net margin of 5.00%.Albemarle’s revenue was up 32.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.18) earnings per share. As a group, equities analysts forecast that Albemarle Corporation will post 12.98 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Friday, June 12th will be paid a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, June 12th. Albemarle’s payout ratio is currently -47.51%.

Albemarle Profile

(Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.